Oxford and AstraZeneca have the first coronavirus vaccine to enter the final stages of human testing.
Inovio was granted $71 million from the Department of Defense for their vaccine development. The company is also developing needleless devices to inject it.
Chinese company Clover has begun Phase 1 trials for their coronavirus vaccine.
Moderna is on track to get their vaccine distributed in 2021. With government help, self-manufacturing, and experience, they’ve got a strong chance at it.